Deep Convolutional Neural Network Mechanism Assessment of COVID-19 Severity

• Published in: BioMed research international Vol. 2022; pp. 1289221 - 14
• Main Authors: Nirmaladevi, J., Vidhyalakshmi, M., Edwin, E. Bijolin, Venkateswaran, N., Avasthi, Vinay, Alarfaj, Abdullah A., Hirad, Abdurahman Hajinur, Rajendran, R. K., Hailu, TegegneAyalew
• Format: Journal Article
• Language: English
• Published: United States Hindawi 2022; Hindawi Limited
• Subjects: Algorithms; Artificial intelligence; Artificial neural networks; Chest; Coronaviruses; COVID-19; COVID-19 - diagnostic imaging; Decision making; Deep Learning; Disease transmission; Epidemics; Fatalities; Feature selection; Humans; Illnesses; Infections; Machine learning; Medical imaging; Medical research; Mortality; Neural networks; Neural Networks, Computer; Optimization; Pandemics; Patients; Radiography, Thoracic - methods; Radiology; Self evaluation; Tomography; Viral diseases; X-rays; China
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2022/1289221

As an epidemic, COVID-19’s core test instrument still has serious flaws. To improve the present condition, all capabilities and tools available in this field are being used to combat the pandemic. Because of the contagious characteristics of the unique coronavirus (COVID-19) infection, an overwhelming comparison with patients queues up for pulmonary X-rays, overloading physicians and radiology and significantly impacting the quality of care, diagnosis, and outbreak prevention. Given the scarcity of clinical services such as intensive care and motorized ventilation systems in the aspect of this vastly transmissible ailment, it is critical to categorize patients as per their risk categories. This research describes a novel use of the deep convolutional neural network (CNN) technique to COVID-19 illness assessment seriousness. Utilizing chest X-ray images as contribution, an unsupervised DCNN model is constructed and suggested to split COVID-19 individuals into four seriousness classrooms: low, medium, serious, and crucial with an accuracy level of 96 percent. The efficiency of the DCNN model developed with the proposed methodology is demonstrated by empirical findings on a suitably huge sum of chest X-ray scans. To the evidence relating, it is the first COVID-19 disease incidence evaluation research with four different phases, to use a reasonably high number of X-ray images dataset and a DCNN with nearly all hyperparameters dynamically adjusted by the variable selection optimization task.